Interpretation on updated guidelines for recurrent spontaneous abortion
ZHANG Shuyun
ZHANG Hong
Abstract:Recurrent spontaneous abortion(RSA)is an important issue affecting women's reproductive health.The occurrence of RSA not only has a negative impact on women's physical and psychological health,but also imposes a heavy burden on families and society.With the deepening of research on RSA,various countries have successively updated multiple guidelines in order to provide scientific basis for clinical diagnosis and treatment.This paper aims to comprehensively interpret the expert consensus on diagnosis and management of recurrent spontaneous abortion(2022),the European Society of Human Reproduction and Embryology(ESHRE)guideline:recurrent pregnancy loss(2022),the Royal College of Obstetricians and Gynaecologists guideline:recurrent miscariage(2023),and Australasian recurrent pregnancy loss clinical management guideline 2024 part Ⅰ and comparatively analyzes the differences and consensuses in the etiology,diagnosis and treatment plans of RSA among different countries and regions,and explores the core contents and clinical applications of each guideline,providing reference and guidance for clinical practice,promoting the understanding and management of RSA in various clinical and research institutions,and improving the reproductive health level of the women.
Keywords:Recurrent spontaneous abortion(RSA)GuidelineConsensusEtiologyClinical practiceInterpretation
Publication Date:2025-06-30
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:6( 600-605 )
Chinese Journal of New Clinical Medicine

Chinese Journal of New Clinical Medicine

ISTIC
ISSN:1674-3806
Year, Vol.(Issue):2025,18(6)